Publication | Open Access
Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
32
Citations
28
References
2022
Year
In this study, 57% of N-ERD patients tolerated higher doses of aspirin under dupilumab therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1